{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:37:12Z","timestamp":1779896232121,"version":"3.53.1"},"reference-count":22,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Extramedullary plasmacytoma of the head and neck is a rare indolent neoplasm. Radiotherapy is often the preferred treatment option with excellent local control and survival. The risk of local recurrence or transformation to multiple myeloma is 10\u201330%. In our case-cohort, thorough, sensitive initial evaluation for disseminated clonal disease and the incorporation of surgery led to excellent results with no recurrences or systemic progression.<\/jats:p>","DOI":"10.4081\/hr.2020.8396","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T11:25:34Z","timestamp":1605612334000},"page":"8396","source":"Crossref","is-referenced-by-count":6,"title":["Surgery Results in Low Relapse and Progression Rates in Extramedullary Plasmacytoma of the Head and Neck: A Case Cohort and Review of the Literature"],"prefix":"10.3390","volume":"12","author":[{"given":"Matevz","family":"Skerget","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Dovsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samo","family":"Zver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hed.20821","article-title":"Solitary extramedullary plasmacytoma of the head and neck-Long-term outcome analysis of 68 cases","volume":"30","author":"Bachar","year":"2008","journal-title":"Head Neck"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.21147\/j.issn.1000-9604.2017.05.08","article-title":"Management of extramedullary plasmacytoma: Role of radiotherapy and prognostic factor analysis in 55 patients","volume":"29","author":"Wen","year":"2017","journal-title":"Chin J Cancer Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3","article-title":"Extramedullary plasmacytoma","volume":"85","author":"Alexiou","year":"1999","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41375-018-0099-8","article-title":"Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset","volume":"32","author":"Goyal","year":"2018","journal-title":"Leukemia"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12885-016-3015-5","article-title":"Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA","volume":"17","author":"Thumallapally","year":"2017","journal-title":"BMC Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.7314\/APJCP.2015.16.9.3741","article-title":"Radiotherapy alone is associated with improved outcomes over surgery in the management of solitary plasmacytoma","volume":"16","author":"Li","year":"2015","journal-title":"Asian Pacific J Cancer Prev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2018.05.009","article-title":"Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the international lymphoma radiation oncology group","volume":"101","author":"Tsang","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2005.09.019","article-title":"Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: A dose greater than 45 Gy to the target volume improves the local control","volume":"64","author":"Tournier-Rangeard","year":"2006","journal-title":"Int J Radiat Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/cancers12030676","article-title":"Maximizing the clinical benefit of radiotherapy in solitary plasmacytoma: an international multicenter analysis","volume":"12","author":"Elsayad","year":"2020","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1177\/0194599813481334","article-title":"Epidemiologic evidence of superior outcomes for extramedullary plasmacytoma of the head and neck","volume":"148","author":"Gerry","year":"2013","journal-title":"Otolaryngol Neck Surg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.6004\/jnccn.2017.0023","article-title":"Multiple myeloma, Version 3.2017, NCCN Clinical practice guidelines in oncology","volume":"15","author":"Kumar","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0360-3016(02)02780-3","article-title":"Extramedullary plasmacytoma: clinical and histopathologic study","volume":"53","author":"Strojan","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1182\/blood.V128.22.5650.5650","article-title":"Risk of progression in monoclonal gammopathy of undetermined significance (MGUS): results from a population-based screening study","volume":"128","author":"Lindqvist","year":"2016","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1158\/1078-0432.CCR-13-2910","article-title":"Impact of initial FDG-PET\/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma","volume":"20","author":"Fouquet","year":"2014","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijrobp.2005.06.039","article-title":"Outcomes and patterns of failure in solitary plasmacytoma: A multicenter Rare Cancer Network study of 258 patients","volume":"64","author":"Ozsahin","year":"2006","journal-title":"Int J Radiat Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00405-017-4817-z","article-title":"Pattern of care and impact of prognostic factors on the outcome of head and neck extramedullary plasmacytoma: a systematic review and individual patient data analysis of 315 cases","volume":"275","author":"Venkatesulu","year":"2018","journal-title":"Eur Arch Oto-Rhino-Laryngology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2478\/v10019-009-0034-8","article-title":"Influence of surgical treatment and radiotherapy of the advanced intraoral cancers on complete blood count, body mass index, liver enzymes and leukocyte CD64 expression","volume":"43","author":"Dov\u0161ak","year":"2009","journal-title":"Radiol Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1100\/2012\/895765","article-title":"A Review for solitary plasmacytoma of bone and extramedullary plasmacytoma","volume":"2012","author":"Kilciksiz","year":"2012","journal-title":"Sci World J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2141.2004.04834.x","article-title":"Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma","volume":"124","author":"Soutar","year":"2004","journal-title":"Br J Haematol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1300439","article-title":"Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma","volume":"369","author":"Mateos","year":"2013","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ijrobp.2019.10.043","article-title":"Solitary plasmacytoma treated by lenalidomide-dexamethasone in combination with radiation therapy: clinical outcomes","volume":"106","author":"Mignot","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/hr\/article\/download\/8396\/8440","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/hr\/article\/download\/8396\/8457","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.mdpi.com\/2038-8330\/12\/2\/8396\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T07:26:05Z","timestamp":1645601165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/12\/2\/8396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["hr.2020.8396"],"URL":"https:\/\/doi.org\/10.4081\/hr.2020.8396","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]}}}